Abstract: A sweetening composition includes a mixture of isomaltulose as a major component and a sweetener as a minor component, wherein the sweetener is one or more selected from the group consisting of stevia, luo han guo (monk fruit), pentadin, brazzein, monellin, thaumatin, sucralose, aspartame, acesulfame potassium, saccharin, neotame, and advantame, and wherein the sweetening composition has a relative sweetness which is the same as regular sugar.

Abstract: Disclosed is a floating sustained release pharmaceutical dosage form including a drug that is adapted to release the drug over an extended period of time. The buoyant pharmaceutical dosage form provides extended gastric residence time of the formulation so that substantially all of the drug is released in the stomach over an extended period. The pharmaceutical dosage form is formulated with low molecular weight concentrated milk proteins to provide buoyancy to the dosage form which can float in gastric fluid for an extended period, including up to about 48 hours.